Similarly, TGF-β present in the TME can induce BRCA cells to release EVs loaded with PD-L1, while the blockage of TGF-β signaling by a chemical inhibitor (SB431542) reduced the PD-L1 levels of these EVs (Chatterjee et al., 2021). Here, CD274 is linked to invasive breast carcinoma.